Cowealth Medical China Co.,Ltd. (SHA:603122)
China · Delayed Price · Currency is CNY 13.76
+0.20 (1.47%)
Oct 9, 2026, 4:00 PM EDT
Cowealth Medical China Market Cap
Cowealth Medical China has a market cap or net worth of 5.48 billion as of October 9, 2026. It is the 11,559th most valuable company in the world and the 2,861st biggest in China. Its market cap has increased by 114.33% in one year.
Market Cap
5.48B
Enterprise Value
5.37B
Revenue
648.86M
Global Rank
Country Rank
#2,861 China
PE Ratio
n/a
ChartMarket Cap Chart
Since February 16, 2022, Cowealth Medical China's market cap has increased from 2.40B to 5.48B, an increase of 128.19%. That is a compound annual growth rate of 19.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 5.48B | -43.61% |
| Dec 31, 2025 | 9.71B | 248.07% |
| Dec 31, 2024 | 2.79B | -12.92% |
| Dec 29, 2023 | 3.20B | -28.13% |
| Dec 30, 2022 | 4.46B | 85.74% |
| Feb 16, 2022 | 2.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 7.75B |
| Beijing Strong Biotechnologies,Inc. | 7.10B |
| Shanghai Runda Medical Technology | 6.03B |
| Maccura Biotechnology Co.Ltd | 5.79B |
| Shanghai Labway Clinical Laboratory | 4.69B |
| Berry Genomics Co.,Ltd | 3.99B |
| Medicalsystem Biotechnology | 3.96B |
| Guangdong Hybribio Biotech | 3.94B |